Journals / Ortadoğu Tıp Dergisi / 2018 / Cilt: 10 - Sayı: 1

The association of adenoma size with the biochemical parameters and cardio-metabolic risk factors in primary hyperparathyroidism

Primer hiperparatiroidide adenom hacmi ile laboratuvar parametreleri ve kardiyo-metabolik risk faktörlerinin ilişkisi

Pages
13–19
Publication Date
2018-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Adenoma volume has a correlation with parathormone, calcium, phosphorus and vitamin D levels, however, it is not associated with cardio-metabolic risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The studies conducted to investigate the association between biochemical manifestations of hyperparathyroidism such as serum parathyroid hormone, serum calcium, and serum phosphate levels, and parathyroid adenoma weight and volume have conflicting results.
📊
Key Findings & Data:We aimed to investigate whether there is an association of preoperative size of adenoma with laboratory parameters and cardio-metabolic risk factors in patients with primary hyperparathyroidism.Material and Method: Seventy-five patients with PHPT and 96 control subjects were enrolled in the study.
💡
Conclusion & Impact:Conclusions: Adenoma volume has a correlation with parathormone, calcium, phosphorus and vitamin D levels, however, it is not associated with cardio-metabolic risk factors.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Primer hiperparatiroidi · adenoma hacmi · kardiyometabolik risk faktörleri

Abstract

Aim: The studies conducted to investigate the association between biochemical manifestations of hyperparathyroidism such as serum parathyroid hormone, serum calcium, and serum phosphate levels, and parathyroid adenoma weight and volume have conflicting results. We aimed to investigate whether there is an association of preoperative size of adenoma with laboratory parameters and cardio-metabolic risk factors in patients with primary hyperparathyroidism.Material and Method: Seventy-five patients with PHPT and 96 control subjects were enrolled in the study. Demographic, anthropometric and biochemistry data were recorded. Correlation analysis was used for determining the relation between adenoma volume and cardio-metabolic parameters. Preoperative adenoma volume was calculated by the ellipsoid model formula. Results: Mean age was similar between groups (52.69 ± 10.91 to 53.33 ± 7.70, p:0.667). Mean size of adenoma was 1.42 ± 2.62 cm3. Size of adenoma was positively correlated with calcium and parathormone levels and negatively correlated with vitamin D level (p<0.05). Size of adenoma was not correlated with cardio-metabolic risk factors including systolic blood pressure, diastolic blood pressure, age, fasting plasma glucose, lipid profile, body mass index, carotis intima media thickness, CRP and HOMA-IR (p>0.05). PTH, calcium, phosphorus or vitamin D levels were also not correlated cardio-metabolic risk factors. Conclusions: Adenoma volume has a correlation with parathormone, calcium, phosphorus and vitamin D levels, however, it is not associated with cardio-metabolic risk factors.

Özet

Amaç: Primer hiperparatiroidili hastalarda, paratiroid adenom ağırlığı veya hacminin hiperparatiroidinin biyokimyasal parametreleri ile ilişkisini araştıran çalışmaların sonuçları çelişkilidir. Bu çalışmada, primer hiperparatiroidili hastalarda preoperatif adenom hacmi ile labaratuvar parametreleri ve kardiyo-metabolik risk faktörleri arasındaki ilişkinin değerlendirilmesini amaçladık. Gereç ve Yöntemler: Çalışmaya primer hiperparatiroidisi olan 75 hasta ve 96 kontrol olgusu alındı. Demografik, antropometrik ve biyokimyasal veriler kaydedildi. Adenom hacmi ile labaratuvar ve kardiyo-metabolik risk faktörleri arasındaki ilişki korrelasyon analizi ile değerlendirildi. Preoperatif adenoma hacmi ellipsoid model formülü ile hesaplandı. Sonuçlar: Ortalama yaş her iki grupta benzerdi (52.69 ± 10.91 to 53.33 ± 7.70, p:0.667). Ortalama adenom hacmi 1.42 ± 2.62 cm3 idi. Paratiroid adenom hacmi, parathormon ve kalsiyum düzeyleri ile pozitif korrele iken, vitamin D düzeyleri ile negatif korrele idi (p<0.05). Paratiroid adenom hacmi, kardiyo-metabolik risk faktörleri olan sistolik ve diyastolik kan basıncı, yaş, açlık plazma glukozu, lipid profili, vücut kitle indeksi, karotis intima media kalınlığı, CRP ve HOMA-IR ile ilişkili değildi (p>0.05). Parathormon, kalsiyum, fosfor veya vitamin D düzeyleri ile kardiyo-metabolik risk faktörleri arasında ilişki saptanmadı (p>0.05). Sonuç: Paratiroid adenoma hacmi ile parathormon, kalsiyum ve vitamin D düzeyleri arasında korrelasyon olmasına rağmen paratiroid adenoma hacmi ile kardiyo-metabolik risk faktörleri arasında ilişki saptanmadı.

🔖

Cite This Article

KİZİLGUL, M., CALİSKAN, M., Ucan, B., Sencar, E., Sakiz, D., Cakal, E., Ozbek, M. (2018). The association of adenoma size with the biochemical parameters and cardio-metabolic risk factors in primary hyperparathyroidism. Ortadoğu Tıp Dergisi, Cilt: 10 - Sayı: 1, 13–19. https://ajindex.com/articles/30893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Minisola S, Pepe J, Piemonte S C, Cipriani C. The diagnosis and management of hypercalcaemia. BMJ 2015; 350: h2723. Bilezikian JP, Cusano NE, Khan AA, Liu J-M, Marcocci C, Bandeira F. Primary hyperparathyroidism. Nat Rev Dis Prim 2016; 2: 16033. Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998; 37: 34–41.
  2. Fitzpatrick LA, Bilezikian JP, Silverberg SJ. Parathyroid hormone and the cardiovascular system. Curr Osteoporos Rep 2008; 6: 77–83.
  3. Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens 2008; 26: 1390–4.
  4. Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003; 24: 2054–60.
  5. Rienstra M, Lubitz SA, Zhang ML, Cooper RR, Ellinor PT. Elevation of parathyroid hormone levels in atrial fibrillation. J Am Coll Cardiol 2011; 57: 2542–3.
  6. Hagström E, Hellman P, Larsson TE et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009; 119: 2765–71.
  7. Welsh P, Doolin O, McConnachie A et al. Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: The MIDSPAN family study. J Clin Endocrinol Metab 2012; 97: 4578–87.
  8. Folsom AR, Alonso A, Misialek JR et al. Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2014; 168: 296–302
  9. Smith JC, Page MD, John R et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85: 3515–9.
  10. Yu N, Donnan PT, Flynn RW V et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) 2010;73:30–4. Nilsson IL, Åberg J, Rastad J et al. Circadian cardiac autonomic nerve dysfunction in primary hyperparathyroidism improves after parathyroidectomy. Surgery 2003; 134: 1013-9
  11. Piovesan A, Molineri N, Casasso F et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999; 50: 321–8.
  12. Stefenelli T, Abela C, Frank H et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 1997; 82: 106–12.
  13. Randhawa PS, Mace AD, Nouraei SAR, Stearns MP. Primary hyperparathyroidism: Do perioperativ